- Home
- HUSA vs IBIO Comparison
HUSA vs IBIO Comparison
Compare HUSA & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUSA
- IBIO
- Stock Information
- Founded
- HUSA N/A
- IBIO 2008
- Country
- HUSA United States
- IBIO United States
- Employees
- HUSA N/A
- IBIO N/A
- Industry
- HUSA Oil & Gas Production
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- HUSA Energy
- IBIO Health Care
- Exchange
- HUSA Nasdaq
- IBIO Nasdaq
- Market Cap
- HUSA 9.6M
- IBIO 9.3M
- IPO Year
- HUSA N/A
- IBIO N/A
- Fundamental
- Price
- HUSA $0.49
- IBIO $0.98
- Analyst Decision
- HUSA
- IBIO Strong Buy
- Analyst Count
- HUSA 0
- IBIO 3
- Target Price
- HUSA N/A
- IBIO $4.87
- AVG Volume (30 Days)
- HUSA 349.8K
- IBIO 452.8K
- Earning Date
- HUSA 05-09-2025
- IBIO 05-02-2025
- Dividend Yield
- HUSA N/A
- IBIO N/A
- EPS Growth
- HUSA N/A
- IBIO N/A
- EPS
- HUSA N/A
- IBIO N/A
- Revenue
- HUSA $514,839.00
- IBIO $375,000.00
- Revenue This Year
- HUSA N/A
- IBIO $36.00
- Revenue Next Year
- HUSA N/A
- IBIO N/A
- P/E Ratio
- HUSA N/A
- IBIO N/A
- Revenue Growth
- HUSA N/A
- IBIO 650.00
- 52 Week Low
- HUSA $0.39
- IBIO $0.64
- 52 Week High
- HUSA $3.20
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- HUSA 37.06
- IBIO 48.45
- Support Level
- HUSA $0.39
- IBIO $0.75
- Resistance Level
- HUSA $0.72
- IBIO $1.03
- Average True Range (ATR)
- HUSA 0.06
- IBIO 0.08
- MACD
- HUSA -0.01
- IBIO 0.08
- Stochastic Oscillator
- HUSA 29.64
- IBIO 75.74
About HUSA Houston American Energy Corporation
Houston American Energy Corp is an independent oil and gas company focused on the development, exploration, exploitation, acquisition, and production of natural gas and crude oil properties. Its properties, and operations, are in the U.S. Permian Basin, the U.S. Gulf Coast region, particularly Louisiana, and the South American country of Colombia. Geographically, the company currently has operations in two geographical areas, the United States, from where it derives maximum revenue, and Colombia.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.